Impact Factor 6.244 | CiteScore 3.9
More on impact ›

CORRECTION article

Front. Oncol., 21 July 2021 | https://doi.org/10.3389/fonc.2021.731942

Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma

Yicong Yao1,2†, Yi Wang3†, Denglong Wu1* and Baoying Hu4*
  • 1Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China
  • 2School of Medicine, Tongji University, Shanghai, China
  • 3Department of Urology, Affiliated Hospital of Nantong University, Nantong, China
  • 4Department of Immunology, Medical College, Nantong University, Nantong, China

A Corrigendum on
Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma

By Yao Y, Wang Y, Wu D and Hu B (2021). Front. Oncol. 11:666418. doi: 10.3389/fonc.2021.666418

In the published article, there was an error in affiliation 2 and affiliation 4. Instead of affiliation 2 Shanghai Tongji Hospital, Tongji University School of Medicine, Shanghai, China, it should be Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China. Instead of affiliation 4 Department of Immunology, Medical College, Nantong University, Shanghai, China, it should be Department of Immunology, Medical College, Nantong University, Nantong, China.

Furthermore, we exchanged the order of Affiliations 1 and 2. Therefore, the new Affiliation 1 is 1 Department of Urology, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China and the new Affiliation 2 is 2 School of Medicine, Tongji University, Shanghai, China.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: CDC6, prognosis, clear cell renal cell carcinoma, survival, pathway

Citation: Yao Y, Wang Y, Wu D and Hu B (2021) Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma. Front. Oncol. 11:731942. doi: 10.3389/fonc.2021.731942

Received: 28 June 2021; Accepted: 28 June 2021;
Published: 21 July 2021.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2021 Yao, Wang, Wu and Hu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Denglong Wu, wudenglong2009@tongji.edu.cn; Baoying Hu, huby86@ntu.edu.cn

These authors have contributed equally to this work